Biotechnology Assets, S.A. (BST:041)
Germany flag Germany · Delayed Price · Currency is EUR
0.3600
+0.0210 (6.19%)
At close: Jul 3, 2025

Biotechnology Assets Revenue

In the year 2024, Biotechnology Assets had annual revenue of 2.97M EUR, down -24.13%. Biotechnology Assets had revenue of 1.86M in the half year ending December 31, 2024, with 3.34% growth.

Revenue
2.97M
Revenue Growth
-24.13%
P/S Ratio
9.36
Revenue / Employee
87.21K
Employees
34
Market Cap
27.76M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.97M-943.29K-24.13%
Dec 31, 20233.91M950.58K32.14%
Dec 31, 20222.96M-324.07K-9.87%
Dec 31, 20213.28M390.31K13.50%
Dec 31, 20202.89M-345.59K-10.68%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition